Archive for June, 2008

Jun 19 2008

Five Million Hay Fever Sufferers Putting Health At Risk, UK

Published by poster under Uncategorized

Over five million of the 13 million hay fever sufferers across Britain could be taking
inappropriate medicines, putting their health at risk. The Royal Pharmaceutical Society of
(RPSGB) is encouraging people experiencing the symptoms of hay fever to visit
their community pharmacist after new research revealed that the public often misdiagnose the
condition and fail to get the correct treatment.
Allergic rhinitis, known as hay fever, is a condition which is caused by the pollen of specific
seasonal plants, airborne chemicals and dust particles. It is commonly characterised by the
symptoms of sneezing, runny nose and itching eyes*.
A survey, commissioned by the RPSGB, found that a staggering 73% of people who
experience these symptoms fail to seek medical advice before selecting a treatment.
Moreover, the research reveals the damaging effects hay fever can have on sufferers’ quality
of life. The research finds that almost 40% of hay fever sufferers become irritable, and a third
experience difficultly sleeping. Worryingly, 29% have difficultly concentrating and 14% said
their symptoms affected their ability to read - findings which could have significant implications
for school children and students, particularly as the hay fever season clashes with exam time.
More than one in 10 said they are embarrassed about their appearance and avoid socialising,
while one in 20 hay fever sufferers say they avoid leaving the home because of their condition.
David Pruce, RPSGB Director of Practice & Quality Improvement, says:
"The survey results clearly demonstrate the impacts a condition like hay fever can have on
peoples’ lives, with millions suffering unnecessarily. Pharmacists are highly trained health
professionals and experts in medicines - they can play a significant role in the management of
allergies including hay fever.
"The numbers of people failing to seek advice about their symptoms is surprising. There is a
large choice of anti-allergy products available and pharmacists are well placed to advise on
what is best for the individual. Pharmacists can help people recognise symptoms, identify
allergy triggers and select appropriate products. Pharmacists can also suggest life-style
changes that may bring relief from hay fever and advise patients about potential side-effects of
the medicines they may be taking.
"Pharmacies are situated in the places where people live, work and shop and are open at
convenient times without the need to make an appointment."
Notes
Hay Fever
Allergic rhinitis, known as hay fever, is a condition which is caused by the pollen of specific
seasonal plants, airborne chemicals and dust particles, which only occur at certain times of the
year, in people who are allergic to these substances. Cells on the lining of the nose and eyes
release histamine and other chemicals when they come in contact with pollen. This causes
inflammation in the nose (rhinitis) and eyes (conjunctivitis). Hay fever is commonly
characterised by sneezing, runny nose and itching eyes.
*Hay fever symptoms are wide-ranging. They can include the following:
- itching of the nose, mouth, eyes, throat, skin, or any area exposed to the allergen
- runny nose
- watering eyes and/or plugged up ear canals.
- sneezing
- impaired smell
- nasal congestion
- sore throat
- wheezing
- conjunctivitis
- fever
- coughing
- headache
- fatigue
- irritability
The Royal Pharmaceutical Society of Great Britain
The Royal Pharmaceutical Society of Great Britain (RPSGB) is the professional and regulatory
body for pharmacists in England, Scotland and Wales. It also regulates pharmacy technicians
on a voluntary basis, which is expected to become statutory under anticipated legislation. The
primary objectives of the Society are to lead, regulate, develop and represent the profession of
- pharmacy.
Research
Research was carried out by YouGov between 02-04 April 2008, interviewing 1981 people
including 547 hay fever sufferers. The GB population of adults 18+ is (according to ONS)
46,158,100. Therefore the number of hay fever sufferers in Great Britain aged 18 years of age
and above (27.59%) is 12,735,019. Of these, 41.95% agreed that they may have
misdiagnosed their condition, which equates to 5,342,340.
Buy zithromax without prescription Full research results are available on request.
The Royal Pharmaceutical Society of Great Britain
generic cialis online buy | Generic levitra pills no prescription | Buy generic viagra

Comments Off

Jun 19 2008

New Data Demonstrate Efficacy Of Aerius(R) (Desloratadine) In Reducing Allergy Symptoms In Patients With Intermittent Allergic Rhinitis

Published by poster under Uncategorized

New data presented at the XXVII Congress of the European Academy of Allergology and Clinical Immunology (EAACI) in Barcelona, Spain, demonstrate AERIUS® (desloratadine) significantly reduces allergy symptoms, including nasal congestion, sneezing, rhinorrhea, nasal pruritus and ocular pruritus, in patients with intermittent allergic rhinitis (IAR) who experience symptoms lasting less than four days per week or less than four weeks per year. generic soma online buy The results are part of the AERIUS Control: Clinical and Evaluative Profile of Treatment (ACCEPT) trials, which were conducted in collaboration with the Global Allergy and Asthma European Network (GA2LEN) and evaluated the safety and efficacy of AERIUS for the treatment of allergic rhinitis (AR), as defined by the updated Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines.
According to the study in patients with IAR, those receiving AERIUS 5 mg for a 15-day treatment period experienced significant reduction in total symptom severity score from baseline versus placebo (-3.01 vs. -2.13; Pgeneric viagra online buy | generic levitra online buy | Buy generic lasix

Comments Off

Jun 19 2008

Gluten-Free Bread Mix Sweeps The Board At First Ever Free-From Food Awards, UK

Published by poster under Uncategorized

Roleys’s teff and corn based gluten-free bread mix carried off the winner’s trophy this month at first ever Free-from Food Awards, organised by Foods Matter, the UK’s only magazine for food allergy, intolerance and sensitivity sufferers.
A packed gathering heard Foods Matter Editor, Michelle Berridale-Johnson, explain why Foods Matter had decided to launch the awards and the criteria on which they had judged the very wide variety of entries.
Other winners included Oatly’s oat based, dairy, gluten, wheat, egg, soya and nut free ‘pouring’ cream, Swedish Glac?©’s creamy chocolate based soya ‘ice cream’, Mrs Crimbles gluten and wheat free chocolate macaroons, a Swedish gluten-free pizza base (Miwell), Delamere Dairies’ dairy free mature goat cheese and Gluten-free Kitchen’s gluten and wheat-free Coffee and Walnut cake.
A full report of the event is to be found on the awards website at uk and in the June issue of Foods Matter.
Also in the June issue:
Dr Moises Calderon on subcutaneous and sublingual immunotherapy for hay fever.
John Scott on the therapeutic use of worms and parasites in both respiratory and digestive conditions.
Three approaches to ME - from nutritionist Margaret Moss and reverse therapist, Rob Mesrie with notes on mitochondrial involvement from Dr Sarah Myhill.
Dr Harry Morrow Brown takes issue with recent research which suggests that attempting to reduce the number of dustmites in your home is a waste of time.
Research reports include:
Could a gut parasite hold the cure for asthma?
Daily contact lenses better for hay fever sufferers
Immunotherapy for peanut allergy
CFS - cortisol and Contemporary Chinese Medicine
Vaccines: autism, major mumps outbreak, delayed administration and type 2 diabetes
Permanent makeup - solution or nightmare?
Can fermentation reduce soya’s allergenicity?
Salicylate sensitivity
Buy levitra without prescription Plus Foods Matter’s regular monthly book reviews, recipe and new product features and childrens’ pages.
Foods Matter is available on subscription only - ??29.95 per annum (12 issues plus new subscriber pack) for an ongoing subscription.
Foods Matter also has an extensive and ever growing website at
Foods Matter
Buy diflucan without prescription | Buy zithromax pills | Buy propecia without prescription

Comments Off

Jun 19 2008

Morria Biopharmaceuticals Plc Announces Regulatory Approval To Commence Phase II Clinical Study Of MRX-4 In Allergic Rhinitis

Published by poster under Uncategorized

Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, announced that it has obtained regulatory
approval from the South African Medicines Control Council (MCC) to initiate
a Phase II study of MRX-4 in 105 patients suffering from allergic rhinitis
(AR). The two-arm, randomized, multi-dose, double-blind, placebo-controlled
study includes a steroid comparator arm.
The study will evaluate the safety, tolerability, and preliminary
efficacy of intranasal MRX-4 in AR patients outside of allergy season as
compared with both placebo and an intranasal steroid. An experimental
multi-functional anti-inflammatory drug (MFAID), MRX-4 is a non-steroidal
potential treatment for AR that was shown to be safe and well tolerated in
a Phase I equivalent trial completed in Israel earlier this year.
"This study will provide valuable data regarding its potential in
allergic rhinitis, including efficacy, tolerability and pharmacokinetic
data," said Dr. Buy acomplia without prescription Yuval Cohen, president of Morria. "We are excited to be
taking this significant step toward testing a potentially safer, more
effective, and more affordable treatment option for the significant
commercial opportunity in the multi-billion dollar allergic rhinitis
market".
ABOUT ALLERGIC RHINITIS
Allergic rhinitis is a common condition that affects nearly 59 million
people in the United States (nearly 20 percent of the population) with a
market of close to $4 billion. Allergic rhinitis is characterized by
inflammation of the nasal membranes accompanied by symptoms that may
include sneezing, nasal congestion, nasal itching and rhinorrhea.
ABOUT MORRIA BIOPHARMACEUTICALS Plc
Morria Biopharmaceuticals Plc is a biopharmaceutical company focused on
the development of novel anti-inflammatory pharmaceuticals termed
multi-functional anti-inflammatory drugs (MFAIDs). This class of drugs
uniquely combines two promising approaches to preventing and reversing
inflammation: first, they control the phospholipase A2 (PLA2) enzyme
family, a known, but previously elusive anti-inflammatory drug target. At
the same time, they also protect cells and tissues against inflammatory
damage. Morria is determined to become a pivotal player in the $20 billion
anti-inflammatory drug market by developing and commercializing novel drugs
for acute pulmonary and gastro-intestinal inflammatory diseases. For more
information, please visit
This is not an invitation nor is it an offer to purchase or subscribe
for shares. This release is only intended for persons falling within the
exception set out in regulation 47 of the Financial Promotion order -
Persons in the business of disseminating information.
Morria Biopharmaceuticals Plc

Generic levitra pills no prescription | Generic clomid pills no prescription | Generic cialis pills no prescription

Comments Off

Jun 18 2008

New Pharmacy Service Offers Hope For Allergy Sufferers, UK

Published by poster under Uncategorized

Over 20 million people in the UK suffer from allergy at some point in their life and for the majority obtaining the help to know what is causing their problem is virtually impossible. Without the knowledge of what is causing a reaction allergy sufferers are unable to manage their condition properly and often go on to experience increasing health problems.
In response to continual demand from the public contacting Allergy UK requesting advice on where to obtain good credible allergy diagnosis Allergy UK announce today that from 19th May they will be introducing an allergy screening service which will be available through the local pharmacy.
"This is an exciting development for people with allergy and we have listened to those who contact us desperate for help. They want a local, affordable service where they can feel confident in the advice being given" said Muriel Simmons CEO of Allergy UK. "Buy clomid without prescription We are delighted to be working with the National Pharmacy Association to introduce this much needed service. The local pharmacy is often the first place that people turn to for advice with a health problem and it is therefore logical to establish a high quality allergy screening service within the pharmacy."
The service will offer a consultation during which a full clinical history will be taken by the pharmacist who will have undergone special training both by the Centre for Postgraduate Pharmacy Education at Manchester University and with the Clinical Director of Allergy UK. On-going support and information for the allergy sufferer will then be provided by Allergy UK.
"We needed to be sure that pharmacists received the best possible training to enable them to undertake the detailed clinical history required for good diagnosis. Any sufferer going to a pharmacist bearing the Allergy UK accreditation can be assured that the person they are seeing is a highly trained healthcare professional" said Jules Payne Deputy CEO and Head of Pharmacy Services for Allergy UK.
The Allergy Screening service will be a central part of the 2008 National Pharmacy Association ‘Ask your Pharmacist’ Campaign. It is planned that from May 19th (National Allergy Week) the service will be rolled out in selected pharmacies. Initially there will be 600 pharmacists around the UK wanting to introduce the service and we are working hard to deliver training to each of these. As at 19 May we will have at least one pharmacist delivering the service in 51 of the 152 PCT areas in England. Our ultimate objective is to provide pharmacy based allergy screening services in every community in the UK with eventual roll out in Northern Ireland, Scotland and Wales.
John Turk, Chief Executive from the National Pharmacy Association said "I am delighted that our members will be able to offer a solution to those needing an allergy screening service. Pharmacists are in the right place and have the right training to provide improved access to this service."
Notes
- 1 in 3 of the population suffer from allergy at some point in their life.
- Asthma, Rhinitis and eczema have tripled in the last 20 years.
- 1 in 5 of the population suffer from asthma.
- 12 million people are allergic to cats.
- Peanut allergy has tripled in the last three year.10 years ago it was a very rare condition.
- 8% of healthcare workers suffer from latex allergy yet in 1979 only 2 cases were known.
- 40% of children suffer from allergy.
- 25% of all young people between the ages of 11 -21 suffer from hayfever.
- There is approximately only one consultant allergist for every 2 million of the population.
The National Pharmacy Association (NPA) was established in 1921 as the trade association of community pharmacy owners. Currently virtually all community pharmacy owners in the UK are in voluntary membership.
National Pharmacy Association
Buy generic soma | Generic cipro pills no prescription | Buy generic lasix

Comments Off

« Prev - Next »